Ceapro
Edmonton · Founded 1997
About Ceapro
Ceapro, a biotechnology company, engages in developing and commercializing functionally active ingredients in the United States, Canada, Germany, China, and internationally. It is involved in the development and application of technology to the production of extracts and active ingredients from oats and other renewable plant resources. Ceapro adds value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. Its products include natural active ingredients comprising beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides that are marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; natural anti-aging skincare products; and veterinary therapeutic products, such as oat shampoos, ear cleansers, and dermal complexes/conditioners. Ceapro's products and technologies that are under research and development, or pre-commercial stage comprise a platform using its beta glucan formulations to deliver compounds for treatments in the personal and healthcare sectors; various novel enabling technologies, including Pressurized Gas eXpanded drying technology; new oat variety and technologies to enhance the content of avenanthramides; and CeaProve, a diabetes test meal to screen pre-diabetes and to confirm diabetes diagnosis. It began operation in 1997, with its headquarters in Edmonton in Canada.
Company Facts
- Founded: 1997
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $1.7M
- Funding stage: M&A
- Last round: Grant (Nov 2021)
- Ticker: cve:CZO
- Website: http://ceapro.com
- Phone: (780) 421-4555
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ceapro-2216586 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.